Steris Healthcare Private Limited

Gliclazide
Gliclaglaze 40 Also Available on PCD Pharma Franchise.is an oral hypoglycemic (anti-diabetic) medication used to control blood sugar levels in people with type 2 diabetes mellitus. It belongs to a class of medications called sulfonylureas. Gliclaglaze 40 works by stimulating the release of insulin from the pancreas, which helps lower blood sugar levels.The typical starting dose of Gliclaglaze  is 40 mg once daily, taken with breakfast. However, the dosage may vary depending on individual factors such as the severity of diabetes, response to treatment, and other medications being taken. It's important to follow your doctor's instructions regarding dosage and administration of Gliclaglaze 40.

PAFAGOLD M 500 Also Available on PCD Pharma Franchise. PAFAGOLD M 500 combines Dapaflozin (10 mg) and Metformin SR (500 mg) to provide an effective solution for managing type 2 diabetes. This combination medication helps in controlling blood sugar levels, improving insulin sensitivity, and reducing the risk of diabetes-related complications.

• Dapaflozin: Inhibits the sodium-glucose co-transporter-2 (SGLT2) in the kidneys, preventing glucose reabsorption and promoting its excretion through urine.
• Metformin SR: Decreases hepatic glucose production, improves insulin sensitivity, and enhances peripheral glucose uptake, providing sustained blood sugar control.

• Management of type 2 diabetes mellitus
• Improvement of glycemic control
• Reduction of postprandial blood sugar levels
• Decrease in the risk of cardiovascular events in diabetic patients

PCD Pharma PAFAGOLD M 500 is an oral antidiabetic medication that combines Dapaflozin, an SGLT2 inhibitor, and Metformin SR, a biguanide. This combination aims to provide comprehensive blood glucose management by targeting different mechanisms in the body.

• Hypoglycemia (when used with other antidiabetic agents)
• Gastrointestinal issues (nausea, diarrhea)
• Urinary tract infections
• Genital infections
• Dizziness
• Increased urination

• Dosage: Take as prescribed by your healthcare provider. Do not alter the dosage without medical advice.
• Precautions:
  • Monitor kidney function regularly.
  • Maintain proper hydration to prevent dehydration.
• Interactions: Inform your doctor about all medications and supplements you are taking to avoid potential interactions.
• Contraindications: Not suitable for patients with severe renal impairment, type 1 diabetes, or diabetic ketoacidosis.

GLIMITERIS 2 Also Available on PCD Pharma Franchise. GLIMITERIS 2 containing Glimepiride (2mg), is a medication widely used to manage type 2 diabetes mellitus. It belongs to the class of drugs known as sulfonylureas, which help to control blood sugar levels in individuals with this condition. Maintaining optimal blood sugar levels is crucial for preventing complications related to diabetes, such as cardiovascular diseases and nerve damage.

• Stimulates Insulin Release: Glimepiride works by stimulating the pancreas to release insulin, a hormone that helps lower blood sugar levels.
• Increases Insulin Sensitivity: It enhances the sensitivity of muscle and fat cells to insulin, promoting better glucose uptake and utilization.
• Reduces Glucose Production: The medication also helps decrease the amount of glucose produced by the liver.

• Type 2 Diabetes Management: Primarily used to control blood sugar levels in adults with type 2 diabetes.
• Adjunct to Diet and Exercise: Often prescribed along with diet and exercise to enhance its effectiveness.

PCD Pharma Glimepiride is an oral diabetes medication that helps manage blood sugar levels by increasing insulin production and improving insulin sensitivity. It is effective for individuals with type 2 diabetes who cannot control their blood sugar levels through diet and exercise alone.

• Common Side Effects: May include headache, nausea, and dizziness.
• Hypoglycemia: One of the significant side effects is low blood sugar, which can cause symptoms like sweating, shakiness, and confusion.
• Weight Gain: Some patients may experience slight weight gain.

• Monitor Blood Sugar Levels: Regular monitoring of blood sugar levels is essential to avoid hypoglycemia.
• Inform Your Doctor: Always inform your healthcare provider about any other medications you are taking to avoid interactions.
• Avoid Alcohol: Alcohol can interfere with the effectiveness of Glimepiride and increase the risk of low blood sugar.

Glimepiride 4 mg & Metformin Hydrochloride 500 mg Also Available on PCD Pharma Franchise. Glimepiride 4 mg & Metformin Hydrochloride 500 mg marketed under the brand name SEIZMET G4, is a combination medication used to manage type 2 diabetes. This powerful combination helps improve blood sugar control and enhances overall diabetes management.

• Glimepiride stimulates the pancreas to produce more insulin, helping to lower blood sugar levels.
• Metformin Hydrochloride reduces glucose production in the liver and improves insulin sensitivity, allowing the body to use insulin more effectively.

• Prescribed for the management of type 2 diabetes in adults.
• Helps to improve glycemic control when diet and exercise alone are insufficient.
• Can be used as a part of a comprehensive diabetes management plan.

• A fixed-dose combination medication that combines two anti-diabetic agents.
• Each tablet contains 4 mg of PCD Pharma Glimepiride and 500 mg of Metformin Hydrochloride.
• Typically taken once or twice daily with meals to reduce the risk of gastrointestinal side effects.

• Common side effects include nausea, diarrhea, and stomach pain.
• Hypoglycemia (low blood sugar) may occur, especially when combined with other anti-diabetic medications.
• Rare but serious side effects include lactic acidosis, which requires immediate medical attention.

• Not suitable for individuals with severe kidney disease or metabolic acidosis.
• Regular monitoring of blood sugar levels and kidney function is recommended.
• Alcohol intake should be limited, as it can increase the risk of lactic acidosis.
• Consult with a healthcare provider before starting or changing dosage.

Composition Name: Pre & Probiotic Capsule

Description: 
KETORENAL PREPROB 45 is a nutritional supplement formulated with a potent blend of probiotics and prebiotics to support digestive health. It contains beneficial strains such as Streptococcus thermophilus, Lactobacillus acidophilus, and Bifidobacterium longum, along with Fructo-Oligosaccharides that help nourish good gut bacteria. This combination works to maintain a healthy intestinal balance, improve digestion, and strengthen the body’s natural immune response.

SEIZMET G 2 Also Available on PCD Pharma Franchise. SEIZMET G 2 combines Glimepiride (2mg) and Metformin HCI SR (500mg) to manage type 2 diabetes. This combination helps control blood sugar levels and improve insulin sensitivity, providing an effective treatment for those needing dual therapy.

• Glimepiride: A sulfonylurea that stimulates the pancreas to release insulin.
• Metformin HCI SR: A biguanide that reduces glucose production in the liver and improves insulin sensitivity.

• Controls blood sugar in type 2 diabetes
• Helps prevent diabetes complications such as neuropathy and cardiovascular issues
• Enhances insulin sensitivity and pancreatic function

• Glimepiride 2mg
• Metformin HCI SR 500mg

• Hypoglycemia (low blood sugar)
• Nausea and vomiting
• Diarrhea
• Dizziness
• Abdominal pain

• Monitor blood sugar regularly
• Avoid alcohol consumption
• Not suitable for type 1 diabetes or diabetic ketoacidosis
• Consult a doctor if pregnant or breastfeeding

GLICLAGLAZE M 40 Also Available on PCD Pharma Franchise.GLICLAGLAZE M 40 combines Gliclazide (40mg) and Metformin (500mg), providing a potent solution for managing type 2 diabetes. This combination targets blood sugar control, helping patients maintain healthy glucose levels.

How Does PCD Pharma Products GLICLAGLAZE M 40 Work?

Gliclazide:

• Stimulates insulin secretion from the pancreas.
• Enhances insulin sensitivity and reduces glucose production.

Metformin:

• Decreases hepatic glucose production.
• Improves peripheral glucose uptake and utilization.

Uses of GLICLAGLAZE M 40

• Effective management of type 2 diabetes.
• Helps achieve better glycemic control.
• Reduces the risk of diabetes-related complications.

What is GLICLAGLAZE M 40?

PCD Pharma GLICLAGLAZE M 40 is a prescription medication combining Gliclazide and Metformin, designed for patients who require both drugs to manage their diabetes effectively.

Side Effects

• Common: Nausea, diarrhea, stomach pain.
• Rare: Hypoglycemia, lactic acidosis, allergic reactions.

Safety Information

• Monitor blood sugar regularly.
• Follow prescribed dietary and exercise regimen.
• Inform your doctor about any other medications you're taking.

Gliclazide SR (30 mg) Also Available on PCD Pharma Franchise. Gliclazide SR (30 mg) known by its brand name GLICLAGLAZE MR 30, is a sustained-release oral medication used to treat type 2 diabetes. It aids in controlling blood sugar levels and is a vital part of diabetes management.

How Does PCD Pharma Product Work?

• Sulfonylurea Class: PCD Pharma Gliclazide belongs to the sulfonylurea class of drugs.
• Stimulates Insulin Secretion: It works by stimulating the pancreas to release more insulin.
• Improves Insulin Sensitivity: Enhances the body's sensitivity to insulin, thereby improving glucose utilization.

Uses of Gliclazide SR (30 mg)

• Type 2 Diabetes Management: Helps in lowering blood glucose levels when combined with proper diet and exercise.
• Glycemic Control: Aims to achieve better control over blood sugar fluctuations throughout the day.

What is Gliclazide SR (30 mg)?

• Sustained-Release Formulation: The SR (sustained-release) formulation ensures a gradual release of the drug, providing a prolonged therapeutic effect.
• Daily Dosing: Typically taken once daily, with or after breakfast, for convenience and adherence.

Side Effects

•  
  • Hypoglycemia (low blood sugar levels).
  • Nausea and dizziness.
  • Weight gain.
  • Allergic skin reactions.

Safety Information

• Contraindications: Not suitable for individuals with type 1 diabetes or diabetic ketoacidosis.
• Monitoring: Regular monitoring of blood sugar levels is essential.

Gliclazide 60 mg, marketed under the brand name GLICLAGLAZE  MR 60, is a medication primarily used to manage type 2 diabetes. This extended-release formulation helps control blood sugar levels, reducing the risk of diabetes-related complications.

How Does It Work?

Gliclazide belongs to the sulfonylurea class of drugs. It stimulates the pancreas to release insulin, which in turn lowers blood glucose levels. This formulation ensures a gradual release of the medication, providing sustained blood sugar control throughout the day.

Uses of Gliclazide 60 mg

• Type 2 Diabetes Management: Helps maintain blood sugar levels in individuals with type 2 diabetes.
• Improves Insulin Sensitivity: Enhances the body's response to insulin.
• Reduces Complications: Lowers the risk of diabetes-related complications such as neuropathy and retinopathy.

What is GLICLAGLAZE MR 60?

GLICLAGLAZE MR 60 is an extended-release version of Gliclazide. It is designed to be taken once daily, offering a convenient and effective way to manage blood sugar levels.

Side Effects

• Hypoglycemia: Low blood sugar levels can occur, especially if meals are skipped.
• Digestive Issues: Nausea, vomiting, or diarrhea may be experienced.
• Allergic Reactions: Rash, itching, or swelling can occur in some individuals.
• Dizziness: A possible side effect that may affect the ability to perform tasks requiring alertness.

Safety Information

• Dosage: Follow the prescribed dosage and schedule.
• Monitoring: Regularly monitor blood sugar levels.
• Diet and Exercise: Maintain a balanced diet and regular exercise routine.
• Alcohol: Limit alcohol consumption as it can affect blood sugar levels.
• Pregnancy and Breastfeeding: Consult a healthcare provider before use.

Sitagliptin (50mg) Also Available on PCD Pharma Franchise. Sitagliptin (50mg)  marketed under the brand name ST-GLIPTIN 50, is a widely used medication for managing type 2 diabetes. It is a part of the DPP-4 inhibitors class, designed to help control blood sugar levels in adults.

• DPP-4 Inhibition: Sitagliptin works by inhibiting the enzyme dipeptidyl peptidase-4 (DPP-4), which increases the levels of incretin hormones.
• Enhanced Insulin Production: These hormones help increase insulin production in response to meals.
• Reduced Glucagon Release: It also lowers the amount of glucose produced by the liver by reducing glucagon release.

• Type 2 Diabetes Management: Sitagliptin is primarily used to improve blood sugar control in adults with type 2 diabetes.
• Combination Therapy: It can be used alone or in combination with other diabetes medications like metformin.

Sitagliptin (50mg) is an oral antidiabetic medication that helps regulate blood sugar levels in patients with type 2 diabetes. It is not suitable for treating type 1 diabetes or diabetic ketoacidosis.

• Common Side Effects: Headache, upper respiratory infection, and nasopharyngitis.
• Serious Side Effects: Pancreatitis, severe joint pain, and allergic reactions.

• Kidney Function Monitoring: Regular monitoring of kidney function is recommended.
• Hypoglycemia Risk: Low risk of hypoglycemia when used alone, but caution is needed when combined with other antidiabetic drugs.
• Consultation: Always consult a healthcare provider before starting or stopping the medication.

ST GLIPTIN GM 50+1000+2 is an advanced triple-action oral anti-diabetic tablet formulated for effective management of Type 2 Diabetes Mellitus (T2DM). This combination medicine brings together Sitagliptin, Metformin Hydrochloride, and Glimepiride, offering a synergistic approach to controlling blood glucose levels. By targeting multiple pathways involved in diabetes, it helps patients maintain stable blood sugar and reduces the risk of long-term complications associated with uncontrolled diabetes.

ST GLIPTIN GM 50+1000+2 is primarily prescribed for:

• Management of Type 2 Diabetes Mellitus: Helps control elevated blood sugar in adults whose diabetes is not adequately managed by diet, exercise, or monotherapy.

• Prevention of Diabetes Complications: Supports the reduction of risks associated with chronic hyperglycemia, such as neuropathy, retinopathy, kidney disease, and cardiovascular disorders.

• Complementary Therapy: Can be used alongside lifestyle modifications, including diet and exercise, for better diabetes management.

This combination is suitable for patients who need a triple-action medication to achieve optimal glycemic control and improve overall metabolic health.

The ST GLIPTIN GM 50+1000+2 tablet offers multiple benefits due to the unique mechanism of its three components:

1. Sitagliptin (50 mg)

• Acts as a DPP-4 inhibitor, increasing levels of incretin hormones.

• Enhances insulin release from the pancreas after meals.

• Reduces glucose production in the liver.

2. Metformin Hydrochloride (1000 mg)

• Improves insulin sensitivity, allowing cells to use glucose more effectively.

• Reduces hepatic glucose output, aiding in fasting blood sugar control.

• Helps maintain stable weight, as it does not cause significant weight gain.

3. Glimepiride (2 mg)

• Stimulates the pancreas to secrete insulin, particularly effective in controlling postprandial glucose.

• Complements the action of Sitagliptin and Metformin for overall glycemic balance.

Combined Benefits:

• Offers triple mechanism glucose control for enhanced efficacy.

• Reduces fluctuations in blood sugar levels throughout the day.

• Lowers the risk of long-term complications, such as cardiovascular disease and kidney damage.

• Improves patient adherence by combining three medications into a single tablet.

• Supports better management of both fasting and post-meal blood sugar levels.

While ST GLIPTIN GM 50+1000+2 is generally well-tolerated, some patients may experience:

Common Side Effects:

• Mild hypoglycemia (low blood sugar)

• Nausea, vomiting, or upset stomach

• Diarrhea or abdominal discomfort

• Headache or dizziness

• Fatigue

Serious Side Effects (rare):

• Severe hypoglycemia (especially in combination with other medications)

• Lactic acidosis (a rare but serious risk associated with Metformin)

• Allergic reactions (rash, itching, swelling)

• Pancreatitis (inflammation of the pancreas)

• Liver enzyme abnormalities

Seek immediate medical attention if severe symptoms occur.

Managing blood sugar levels is crucial for people living with type 2 diabetes mellitus (T2DM). Poorly controlled blood sugar can lead to serious health complications, including heart disease, kidney damage, and nerve problems. Combining the right medicines with lifestyle modifications is essential for effective diabetes management.

SEIZMET G2 850 is a combination antidiabetic tablet containing Metformin Hydrochloride Prolonged-Release 850 mg and Glimepiride IP 2 mg. This formulation is designed to help control blood glucose levels effectively in patients with type 2 diabetes, while reducing the risk of complications associated with chronic hyperglycemia.

This article provides a detailed overview of SEIZMET G2 850, covering its composition, mechanism of action, uses, benefits, dosage, side effects, precautions, and frequently asked questions.

Type 2 diabetes mellitus (T2DM) occurs when the body either resists the effects of insulin or fails to produce enough insulin to maintain normal blood sugar levels. Key factors contributing to type 2 diabetes include:

• Unhealthy diet high in sugar and fats

• Sedentary lifestyle

• Obesity or overweight

• Genetics and family history

• Stress and hormonal imbalances

Left untreated, high blood sugar levels can damage organs, leading to complications such as cardiovascular disease, neuropathy, nephropathy, and retinopathy.

SEIZMET G2 850 Tablets combine two effective antidiabetic agents:

1. Metformin Hydrochloride Prolonged-Release 850 mg

Metformin is a biguanide class medicine that helps lower blood glucose by:

• Reducing glucose production in the liver

• Improving insulin sensitivity in muscle and fat cells

• Enhancing peripheral glucose uptake

The prolonged-release (PR) formulation ensures gradual release of the drug, reducing gastrointestinal side effects and allowing once-daily dosing in some cases.

2. Glimepiride IP 2 mg

Glimepiride is a sulfonylurea class drug that stimulates the pancreas to release more insulin. It is effective in patients whose insulin production is reduced and complements the action of metformin in controlling blood sugar.

SEIZMET G2 850 controls blood sugar through dual mechanisms:

1. Metformin PR 850 mg: Reduces hepatic glucose output and improves insulin sensitivity, lowering fasting blood sugar levels.

2. Glimepiride 2 mg: Stimulates insulin release from pancreatic beta cells, particularly effective for post-meal glucose spikes.

Together, this combination helps achieve stable blood sugar levels throughout the day, targeting both fasting and postprandial glucose.

SEIZMET G2 850 is primarily prescribed for:

1. Type 2 Diabetes Mellitus (T2DM)

   • Helps patients maintain target blood sugar levels

   • Reduces fluctuations in glucose levels

2. Patients Not Controlled on Monotherapy

   • Used when either metformin or glimepiride alone is insufficient to achieve glycemic control

3. Adjunct to Lifestyle Modifications

   • Works best alongside diet, exercise, and weight management

• Controls both fasting and postprandial blood sugar effectively

• Reduces the risk of long-term diabetes complications

• Convenient combination tablet reduces pill burden

• Prolonged-release metformin minimizes gastrointestinal side effects

Composition Name:  Dapagliflozin & Metformin Tablets

GLIDAPAFLOZIN TRIO 2 is an advanced triple-combination oral medication designed for the effective management of type 2 diabetes mellitus. It combines three powerful antidiabetic agents—Dapagliflozin, Glimepiride, and Metformin Hydrochloride (Extended Release)—that work together through different mechanisms to help control blood sugar levels.

Type 2 diabetes is a chronic metabolic condition where the body either does not produce enough insulin or becomes resistant to insulin, leading to elevated blood glucose levels. If not managed properly, diabetes can lead to serious complications such as heart disease, kidney damage, nerve problems, and vision loss.

GLIDAPAFLOZIN TRIO 2 helps manage diabetes by:

• Improving insulin sensitivity

• Increasing insulin secretion

• Reducing glucose production in the liver

• Removing excess glucose through urine

This triple therapy approach makes GLIDAPAFLOZIN TRIO 2 a comprehensive treatment option for patients who require stronger glycemic control.

Composition Name:   Dapagliflozin 10 mg,Vildagliptin SR 100 mg And Metformin SR 500 mg Tablets


DAPAVILDA MET 10/100/500 is a clinically advanced triple-combination tablet formulated for the effective management of Type 2 Diabetes Mellitus in adults. This powerful combination integrates three well-established anti-diabetic agents—Dapagliflozin, Vildagliptin, and Metformin—to deliver comprehensive glycemic control. Designed with sustained-release (SR) technology, this formulation ensures prolonged action, improved patient compliance, and stable blood sugar levels throughout the day.

Key Composition

• Dapagliflozin 10 mg
• Vildagliptin SR 100 mg
• Metformin SR 500 mg

Mechanism of Action
DAPAVILDA MET works through a multi-targeted approach to control blood glucose:

• Dapagliflozin helps remove excess glucose through urine by inhibiting glucose reabsorption in the kidneys.
• Vildagliptin SR enhances insulin secretion and reduces glucagon levels, particularly after meals.
• Metformin SR reduces hepatic glucose production and improves insulin sensitivity.

This synergistic action helps maintain balanced blood sugar levels while reducing the risk of complications associated with uncontrolled diabetes.

Key Benefits

• Provides triple-action glucose control for better diabetes management
• Helps reduce both fasting and postprandial blood sugar levels
• Supports weight management due to Dapagliflozin action
• Sustained-release formulation ensures long-lasting effect
• Helps improve insulin sensitivity and pancreatic function
• Reduces the risk of long-term complications such as cardiovascular issues

Indications

• Type 2 Diabetes Mellitus (when diet and exercise alone are insufficient)
• Patients requiring combination therapy for better glycemic control
• Suitable for individuals not adequately controlled with dual therapy

Dosage & Administration

• To be taken as directed by a registered medical practitioner
• Usually recommended once daily with meals to minimize gastrointestinal discomfort
• Do not crush or chew the tablet; swallow whole with water

Safety Information

• Monitor blood glucose levels regularly
• Not recommended for Type 1 diabetes or diabetic ketoacidosis
• Use with caution in patients with kidney or liver disorders
• Inform your doctor about all ongoing medications

Possible Side Effects
Some patients may experience mild side effects such as nausea, urinary tract infections, headache, or dizziness. These are generally temporary. However, medical advice should be sought in case of persistent symptoms.

Storage Instructions

• Store in a cool, dry place below 25°C
• Protect from moisture and direct sunlight
• Keep out of reach of children

Why Choose DAPAVILDA MET 10/100/500?
DAPAVILDA MET stands out as a reliable and effective triple-combination therapy designed for modern diabetes management. Its scientifically balanced formulation ensures enhanced efficacy, better compliance, and improved quality of life for patients. Ideal for long-term glycemic control, this product is trusted by healthcare professionals for its safety and performance. 

GLIDAPA 3D 10/100/500 SR Also Available on PCD Pharma Franchise. GLIDAPA 3D 10/100/500 SR is a combination medication that includes Dapaflozin (10 mg), Sitagliptin (100 mg), and Metformin SR (500 mg). This medication is specifically formulated for the management of type 2 diabetes. The synergistic effect of these three components helps in achieving better glycemic control for patients.

How Does PCD Pharma Product Work?

• Dapaflozin: Works by inhibiting SGLT2, reducing glucose reabsorption in the kidneys, and promoting glucose excretion through urine.
• Sitagliptin: Enhances the levels of incretin hormones, which increases insulin release and decreases glucagon levels in the bloodstream.
• Metformin SR: Improves insulin sensitivity and reduces glucose production in the liver.

Uses of GLIDAPA 3D 10/100/500 SR

• Improves Glycemic Control: Helps in maintaining target blood glucose levels.
• Reduces HbA1c Levels: Lowers glycated hemoglobin, indicating better long-term blood sugar control.
• Weight Management: Aids in weight reduction as part of a comprehensive diabetes management plan.

What is GLIDAPA 3D 10/100/500 SR?

PCD Pharma GLIDAPA 3D 10/100/500 SR  is an oral antidiabetic medication designed to manage blood sugar levels in adults with type 2 diabetes. It combines three active ingredients to provide a multifaceted approach to diabetes care.

Side Effects

• Nausea

• Diarrhea

• Headache

• Urinary tract infections

• Lactic acidosis

• Severe hypoglycemia

• Pancreatitis

• Kidney problems

Safety Information

• Consult Your Doctor: Always seek medical advice before starting or changing dosage.
• Regular Monitoring: Regularly monitor blood sugar levels and renal function.
• Hydration: Ensure adequate fluid intake to prevent dehydration.
• Avoid Alcohol: Limit alcohol consumption as it can increase the risk of lactic acidosis.
• Pregnancy and Breastfeeding: Consult a healthcare provider as this medication may not be suitable.

VILDIABATE 100 is an oral medication used to manage type 2 diabetes. It contains Vildagliptin (100mg), a dipeptidyl peptidase-4 (DPP-4) inhibitor that helps control blood sugar levels.

• Inhibits DPP-4 Enzyme: Increases incretin levels, which regulate insulin production and glucagon release.
• Enhances Insulin Secretion: Stimulates the pancreas to produce more insulin in response to meals.
• Reduces Glucagon Production: Lowers the amount of glucose produced by the liver.

• Type 2 Diabetes Management: Helps control high blood sugar in adults with type 2 diabetes.
• Combination Therapy: Can be used alone or with other antidiabetic medications for better glycemic control.

VILDIABATE 100 is an oral tablet containing Vildagliptin (100mg). It is prescribed for adults with type 2 diabetes to help control blood sugar levels, particularly when lifestyle modifications like diet and exercise are not enough.

• Common Side Effects:
  • Headache
  • Dizziness
  • Nausea
• Serious Side Effects:
  • Pancreatitis
  • Severe allergic reactions

• Precautions:
  • Monitor liver function regularly.
  • Use caution in patients with renal impairment.
• Contraindications:
  • Hypersensitivity to Vildagliptin
  • Severe hepatic impairment

Glibenclamide, known by the brand name GLIBIMIDE 5, is an oral medication commonly used to manage type 2 diabetes mellitus. It belongs to the class of drugs called sulfonylureas, which help control blood sugar levels by stimulating insulin production.

How Does It Work?

Glibenclamide works by:

• Stimulating the pancreas to release insulin.
• Enhancing the body's response to insulin.
• Reducing blood sugar levels effectively when taken regularly.

Uses of Glibenclamide

Glibenclamide is primarily used to:

• Control high blood sugar in people with type 2 diabetes.
• Prevent complications associated with diabetes, such as kidney damage, blindness, nerve problems, and loss of limbs.
• Improve overall blood sugar control in combination with diet and exercise.

What is GLIBIMIDE 5?

GLIBIMIDE 5 is a branded formulation of Glibenclamide (5 mg). It is specifically designed to:

• Provide a consistent dose for effective blood sugar management.
• Be taken once daily, typically with breakfast, to ensure optimal absorption and efficacy.

Side Effects

• Hypoglycemia (low blood sugar)
• Nausea
• Heartburn
• Weight gain
• Allergic skin reactions

Safety Information

• Monitor blood sugar levels regularly.
• Follow your doctor’s advice on diet and exercise.
• Avoid excessive alcohol consumption.
• Inform your doctor of any other medications you are taking to avoid drug interactions.
• Not recommended during pregnancy or breastfeeding without medical advice.

GLICLAGLAZE M 80 combines two potent medications, Gliclazide (80mg) and Metformin (500mg), to effectively manage Type 2 diabetes. This combination is designed to help patients control blood sugar levels and maintain a healthy lifestyle.

How Does It Work?

Gliclazide

• Stimulates Insulin Production: Gliclazide is a sulfonylurea that increases the release of insulin from the pancreas.
• Improves Insulin Sensitivity: It enhances the body's response to insulin, reducing blood sugar levels.

Metformin

• Reduces Glucose Production: Metformin decreases glucose production in the liver.
• Increases Insulin Sensitivity: It improves insulin sensitivity, helping cells utilize glucose more effectively.

Uses of GLICLAGLAZE M 80

• Type 2 Diabetes Management: Helps control high blood sugar levels in conjunction with a proper diet and exercise.
• Prevention of Complications: Reduces the risk of kidney damage, blindness, nerve problems, and loss of limbs.

What is GLICLAGLAZE M 80?

GLICLAGLAZE M 80 is a prescription medication combining Gliclazide (80mg) and Metformin (500mg). It is specifically formulated to provide dual action against high blood sugar levels in Type 2 diabetes patients.

Side Effects

• Common: Nausea, diarrhea, stomach upset, and headache.
• Severe: Hypoglycemia, lactic acidosis, allergic reactions, and liver issues.

Safety Information

• Monitor Blood Sugar Levels: Regular monitoring is essential to avoid hypoglycemia.
• Avoid Alcohol: Alcohol can increase the risk of lactic acidosis with Metformin.
• Consult Your Doctor: Before starting any new medication, inform your doctor about your medical history.

Teneligliptin, marketed under the brand name TENELIGOLD 20, is a potent medication used in the management of type 2 diabetes mellitus. It belongs to a class of drugs known as dipeptidyl peptidase-4 (DPP-4) inhibitors, which help regulate blood sugar levels.

Teneligliptin works by inhibiting the enzyme DPP-4. This enzyme is responsible for the degradation of incretin hormones, which play a crucial role in regulating glucose metabolism. By inhibiting DPP-4, teneligliptin increases the levels of active incretin hormones, enhancing insulin secretion and decreasing glucagon levels, thereby lowering blood sugar levels.

Teneligliptin is primarily used to:

• Control blood sugar levels in type 2 diabetes patients
• Improve glycemic control as part of a comprehensive diabetes management plan

TENELIGOLD 20 is a pharmaceutical formulation containing 20mg of teneligliptin. It is used as an adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes.

Common side effects of teneligliptin include:

• Headache
• Nasopharyngitis
• Upper respiratory tract infections
• Hypoglycemia when used with other antidiabetic medications

• Monitor blood sugar levels regularly.
• Inform your healthcare provider about any other medications you are taking.
• Use with caution in patients with renal impairment.
• Not recommended for use in patients with type 1 diabetes or diabetic ketoacidosis.

Vildagliptin Also Available on PCD Pharma Franchise. Vildagliptin marketed under the brand name VILDIABATE 50, is an oral medication primarily used to manage type 2 diabetes mellitus. It belongs to the class of drugs known as DPP-4 inhibitors, which help regulate blood sugar levels.

• Increases Insulin Production: Vildagliptin works by inhibiting the enzyme DPP-4, which leads to an increase in insulin secretion in response to meals.
• Decreases Glucagon Release: It reduces the amount of glucose produced by the liver by decreasing the hormone glucagon.
• Improves Blood Sugar Control: By enhancing the body's natural ability to control blood sugar, Vildagliptin helps maintain better glycemic control.

• Type 2 Diabetes Management: Vildagliptin is used alongside diet and exercise to improve blood sugar control in adults with type 2 diabetes.
• Combination Therapy: Often prescribed in combination with other diabetes medications like Metformin.

• DPP-4 Inhibitor: It is a dipeptidyl peptidase-4 inhibitor that enhances the levels of incretin hormones.
• Blood Sugar Regulation: Helps in the regulation of blood glucose levels post meals.

• Common Side Effects: Headache, dizziness, and gastrointestinal discomfort.
• Serious Side Effects: Rarely, it may cause severe pancreatitis or allergic reactions.

• Not for Type 1 Diabetes: PCD Pharma Vildagliptin is not recommended for patients with type 1 diabetes.
• Liver Function Monitoring: Regular liver function tests are advised during treatment.
• Kidney Function: Dosage adjustments may be necessary for patients with renal impairment.

Metformin and Vildagliptin Combination

• Enhanced Efficacy: Combining Vildagliptin with Metformin, another antidiabetic drug, can provide better blood sugar control.

TENELIGOLD M 500 Also Available on PCD Pharma Franchise. TENELIGOLD M 500 is a combination medication that includes Metformin SR (500mg) and Teneligliptin (20mg). This combination is commonly prescribed to manage type 2 diabetes mellitus, helping to control blood sugar levels and improve overall glycemic control.

• Mechanism: Metformin works by reducing glucose production in the liver, improving insulin sensitivity, and enhancing peripheral glucose uptake and utilization.
• Sustained Release (SR): The SR formulation ensures a gradual release of Metformin, providing a prolonged effect and better blood sugar control.

• Mechanism: Teneligliptin is a DPP-4 inhibitor that increases the levels of incretin hormones. These hormones stimulate insulin release and inhibit glucagon release, thereby lowering blood glucose levels.

• Type 2 Diabetes Management: Helps in maintaining optimal blood sugar levels in adults with type 2 diabetes.
• Combination Therapy: Often used when single-drug therapy is insufficient to control blood sugar levels.

PCD Pharma TENELIGOLD M 500 is a dual-action medication combining Metformin SR and Teneligliptin. It is designed to provide comprehensive glycemic control by targeting different mechanisms involved in blood glucose regulation.

• Common Side Effects:
  • Nausea
  • Diarrhea
  • Headache
  • Upper respiratory tract infections
• Serious Side Effects:
  • Lactic acidosis (a rare but serious side effect of Metformin)

THYRORISE 62.5 Also Available on PCD Pharma Franchise. is a highly effective medication formulated to manage and treat hypothyroidism, a condition characterized by an underactive thyroid gland. The thyroid gland plays a crucial role in regulating the body's metabolism, and an insufficient production of thyroid hormones can lead to various health issues such as fatigue, weight gain, and depression. THYRORISE 62.5 provides a precise dose of Thyroxine Sodium, a synthetic form of the naturally occurring thyroid hormone, ensuring that the body's metabolic processes are maintained at optimal levels. This medication is carefully designed to mimic the action of the endogenous hormone, providing relief from the symptoms associated with hypothyroidism and promoting overall well-being.

Key Benefits:

• Effective Thyroid Hormone Replacement: THYRORISE 62.5 effectively replaces the deficient thyroid hormone in individuals with hypothyroidism, helping to restore normal metabolic activity.
• Improves Metabolic Function: By normalizing thyroid hormone levels, this medication aids in the improvement of metabolic processes, leading to increased energy levels and better overall health.
• Supports Weight Management: Proper thyroid function is essential for weight management. THYRORISE 62.5 helps in maintaining a healthy weight by regulating metabolism.
• Enhances Mood and Mental Health: Thyroxine Sodium plays a vital role in brain function. This medication helps alleviate symptoms of depression and cognitive dysfunction associated with hypothyroidism.
• Promotes Heart Health: Adequate thyroid hormone levels are crucial for cardiovascular health. THYRORISE 62.5 supports heart function by ensuring proper thyroid hormone levels.

How Does PCD Pharma Product THYRORISE 62.5 Work?

THYRORISE 62.5 works by supplying the body with Thyroxine Sodium, a synthetic version of the naturally occurring thyroid hormone thyroxine (T4). Once administered, Thyroxine Sodium is absorbed into the bloodstream and converted into triiodothyronine (T3), the active form of the hormone. T3 then interacts with receptors in various tissues, regulating the expression of genes involved in metabolism, growth, and development. This process helps to restore and maintain normal metabolic activity, alleviating the symptoms of hypothyroidism.

Directions for Use:

1. Dosage: Follow your healthcare provider's prescribed dosage instructions. The usual starting dose is one THYRORISE 62.5 tablet taken once daily.
2. Timing: Take the medication at the same time each day, preferably in the morning on an empty stomach, 30 minutes to an hour before breakfast.
3. Swallowing: Swallow the tablet whole with a full glass of water. Do not chew or crush the tablet.
4. Consistency: For best results, take the medication consistently every day and do not miss doses. If a dose is missed, take it as soon as you remember, unless it is close to the time for the next dose. Do not double the dose to make up for a missed one.

Side Effects:

While PCD Pharma THYRORISE 62.5 is generally well-tolerated, some individuals may experience side effects, particularly if the dosage is too high. Common side effects include:

• Increased Heart Rate: Rapid or irregular heartbeat.
• Nervousness: Feelings of anxiety or restlessness.

Teneligliptin 20mg and Dapagliflozin Propanediol Monohydrate 5mg, marketed under the name GLIDAPA TENE 5/20, is a combination medication used to manage type 2 diabetes. This medication leverages the complementary mechanisms of Teneligliptin, a DPP-4 inhibitor, and Dapagliflozin, an SGLT2 inhibitor, to effectively control blood glucose levels.

• Inhibits DPP-4 enzyme
• Increases incretin hormone levels
• Enhances insulin secretion
• Reduces glucagon levels

• Inhibits SGLT2 in kidneys
• Reduces glucose reabsorption
• Increases glucose excretion via urine
• Lowers blood glucose levels

• Manages type 2 diabetes
• Improves glycemic control
• Reduces the risk of cardiovascular events

GLIDAPA TENE 5/20 is a dual-action antidiabetic medication combining Teneligliptin and Dapagliflozin. It is designed to enhance insulin sensitivity, reduce glucose production, and promote glucose excretion, thus maintaining optimal blood sugar levels.

• Hypoglycemia
• Urinary tract infections
• Nasopharyngitis
• Diarrhea
• Headache

• Monitor renal function
• Avoid in severe renal impairment
• Caution in elderly patients
• Stay hydrated to prevent dehydration
• Consult a doctor before use during pregnancy or lactation

DAPA VILDA 10/100 SR Also Available on PCD Pharma Franchise.DAPA VILDA 10/100 SR combines two powerful diabetes medications: Dapagliflozin (10mg) and Vildagliptin SR (100mg). This combination is designed to help manage blood sugar levels in adults with type 2 diabetes mellitus, providing a dual mechanism of action to achieve optimal glycemic control.

Dapagliflozin:

• Mechanism: SGLT2 inhibitor
• Function: Inhibits the reabsorption of glucose in the kidneys, promoting glucose excretion through urine.

Vildagliptin SR:

• Mechanism: DPP-4 inhibitor
• Function: Increases incretin levels, which helps to regulate insulin production and decrease glucagon levels.

• Primary Use: Management of type 2 diabetes mellitus
• Combination Therapy: Used in conjunction with diet and exercise
• Blood Sugar Control: Helps in achieving target glycemic levels

• Urinary tract infections
• Nasopharyngitis
• Hypoglycemia (low blood sugar)
• Dehydration
• Kidney issues
• Pancreatitis

• Contraindications: Not suitable for patients with type 1 diabetes or severe kidney impairment.
• Precautions: Regular monitoring of kidney function and hydration status is recommended.
• Interactions: Inform your doctor of all medications being taken to avoid potential interactions.

• Dosage and formulation: Each tablet contains 60mg of Gliclazide SR and 500mg of Metformin SR.
• Administration: Typically taken once or twice per day with meals to increase efficacy and reduce side effects.

• Contraindications: Not recommended for patients with severe kidney impairment, liver disease, or heart failure.
• Precautions include regular monitoring of blood sugar, renal function, and liver enzymes. To avoid hypoglycemia and other complications, adjust the dosage according to medical advice.

Type 2 Diabetes Mellitus (T2DM) is a chronic metabolic disorder affecting millions of people in India. Characterized by elevated blood glucose levels due to insulin resistance and impaired insulin secretion, T2DM can lead to serious complications like cardiovascular disease, kidney damage, neuropathy, and vision problems if left uncontrolled. Effective blood sugar management is crucial to prevent these complications and maintain overall health.

LINALIGLIP EMPAMET is an advanced, triple-combination therapy designed for comprehensive blood sugar control in adults with type 2 diabetes. It combines Empagliflozin, Linagliptin, and Metformin Hydrochloride (Extended Release) in a single, convenient tablet. This unique formulation targets multiple pathways in glucose regulation, helping patients achieve better glycemic control while minimizing side effects and improving adherence.

Developed with modern clinical insights, LINALIGLIP EMPAMET is a trusted choice for patients seeking effective, long-term diabetes management. Regular use under medical supervision supports fasting and postprandial glucose control, reduces HbA1c levels, and helps prevent complications associated with diabetes.

Empagliflozin is a Sodium-Glucose Co-Transporter 2 (SGLT2) inhibitor. It works by preventing glucose reabsorption in the kidneys and promoting its excretion through urine. This results in:

• Reduced blood glucose levels

• Improved glycemic control without causing hypoglycemia

• Potential benefits for cardiovascular health in patients with diabetes

Linagliptin is a Dipeptidyl Peptidase-4 (DPP-4) inhibitor. It enhances the activity of incretin hormones, which increase insulin secretion and decrease glucagon levels in response to meals. Key benefits include:

• Improved postprandial blood sugar regulation

• Reduced HbA1c levels

• Weight neutrality, making it suitable for overweight patients

Metformin is a first-line therapy for type 2 diabetes. The extended-release (ER) formulation provides sustained glucose control throughout the day. Mechanisms include:

• Decreasing hepatic glucose production

• Improving insulin sensitivity in peripheral tissues

• Supporting weight management and cardiovascular health

Combination Effect: The triple-action mechanism of LINALIGLIP EMPAMET addresses multiple causes of hyperglycemia, providing superior glycemic control, convenience, and improved patient adherence compared to monotherapy.

LINALIGLIP EMPAMET is indicated for adults with type 2 diabetes who require:

• Fasting blood sugar control

• Postprandial blood sugar management

• Reduction in HbA1c levels

• Patients not adequately controlled with diet, exercise, or monotherapy

• Combination therapy for individuals at risk of cardiovascular complications due to diabetes

This triple-combination tablet is particularly suitable for patients who struggle with multiple medications, offering the convenience of once-daily dosing without compromising effectiveness.